Hana Yoshida

Ask VT AI
View News Summary
  • Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
  • Former LSU coach Ed Orgeron expresses strong interest in returning to the program following Brian Kelly's dismissal.
  • US adult obesity rate declines as weight-loss drug use surges in 2025, but diabetes prevalence reaches new high.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Ask VT AI
View News Summary
  • Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
  • Former LSU coach Ed Orgeron expresses strong interest in returning to the program following Brian Kelly's dismissal.
  • US adult obesity rate declines as weight-loss drug use surges in 2025, but diabetes prevalence reaches new high.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Hana Yoshida